After incubation for 10 min, 200 L luciferin solution (containing 20 mM tricine, 1.0 mM MgSO4, 0.1 mM EDTA, 33 mM dithiothreitol, 270 M coenzyme A, 500 M D-luciferin, and 530 M ATP, pH 7.8) was added, and then the firefly luminescence was measured with a BioTek synergy 4 Multi-Mode Microplate Reader
ALT and AST, markers of liver cell damage, frequently decrease during treatment
Industry leaders Novo Nordisk A/S and Eli Lilly and Company currently dominate the market through blockbuster injectable products including Ozempic(R), Wegovy(R), Mounjaro(R) and Zepbound(R)
Multiple sclerosis treatment includes disease-modifying therapies such as interferon beta, glatiramer acetate, and newer oral agents (fingolimod, dimethyl fumarate) or monoclonal antibodies (natalizumab, ocrelizumab)